Fate Therapeutics FATE
NASDAQ FATE
$2.38 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Current Assets (2012 - 2026)

Updated

Fate Therapeutics' Current Assets was $157.95 million in Q2 2026, down 31.4% from $230.4 million a year earlier and down 12.0% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Fate Therapeutics came in at $208.7 million, down 28.5% from FY2024.

  • Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
  • In earlier years, Current Assets was $291.91 million in FY2024 (-12.0%), $331.54 million in FY2023 (-34.0%), $502.07 million in FY2022 (-20.7%) and $633.41 million in FY2021 (+28.1%).
  • The Q2 2026 figure marks the lowest quarterly Current Assets since Q2 2018.
  • Compared with a year earlier, Current Assets has declined for 18 straight quarters, with an average decline of 26.0% over the last eight quarters.
  • The best year-over-year quarter for Current Assets over five years was Q3 2021 (growth of 39.6%); the worst was Q1 2025 (a decline of 37.1%).
  • Per Business Quant data, FATE's Current Assets in the three quarters before Q2 2026 was $179.53 million (Q1 2026), $208.7 million (Q4 2025) and $221.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Fate Therapeutics 277.73 Mn 277.73 Mn - 157.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 157.95 Mn
Mar 31, 2026 179.53 Mn
Dec 31, 2025 208.70 Mn
Sep 30, 2025 221.25 Mn
Jun 30, 2025 230.40 Mn
Mar 31, 2025 248.22 Mn
Dec 31, 2024 291.91 Mn
Sep 30, 2024 310.29 Mn
Jun 30, 2024 319.39 Mn
Mar 31, 2024 394.38 Mn
Dec 31, 2023 331.54 Mn
Sep 30, 2023 364.17 Mn
Jun 30, 2023 392.18 Mn
Mar 31, 2023 437.89 Mn
Dec 31, 2022 502.07 Mn
Sep 30, 2022 535.33 Mn
Jun 30, 2022 599.16 Mn
Mar 31, 2022 599.08 Mn
Dec 31, 2021 633.41 Mn
Sep 30, 2021 693.71 Mn
API Access

Fate Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=FATE&period=max&api_key=YOUR_API_KEY